Cargando…

Thrombotic microangiopathy associated with use of interferon-beta

Interferon-beta is widely used for the treatment of relapsing multiple sclerosis. The drug is usually well tolerated, but autoimmune adverse effects, including kidney disease, have been reported. Only a few cases of hemolytic uremic syndrome-thrombotic microangiopathy associated interferon-alpha hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olea, Teresa, Díaz-Mancebo, Raquel, Picazo, Maria-Luz, Martínez-Ara, Jorge, Robles, Angel, Selgas, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399315/ https://www.ncbi.nlm.nih.gov/pubmed/22815645 http://dx.doi.org/10.2147/IJNRD.S30194

Ejemplares similares

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
por: Malekzadeh, Masoud Mohammad, et al.
Publicado: (2020)

Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis
por: Mahe, Julien, et al.
Publicado: (2013)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021)

Renal thrombotic microangiopathy induced by β-interferon
por: Li Cavoli, Gioacchino, et al.
Publicado: (2011)

Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab
por: Allinovi, Marco, et al.
Publicado: (2017)

Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
por: Ban, Byung H., et al.
Publicado: (2017)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020)

Nintedanib-Induced Renal Thrombotic Microangiopathy
por: Fujita, Takeshi, et al.
Publicado: (2021)

Perindopril/amlodipine-induced thrombotic microangiopathy
por: Periša, Vlatka, et al.
Publicado: (2020)

Tacrolimus: Thrombotic microangiopathy: case report
Publicado: (2021)

Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)

Thrombotic microangiopathy associated with lenvatinib therapy
por: Contreras Angulo, Macarena, et al.
Publicado: (2023)

Acute renal failure, systemic lupus erythematosus and thrombotic microangiopathy following treatment with beta-interferon for multiple sclerosis: case report and review of the literature
por: Hansen, Thomas, et al.
Publicado: (2009)

Thrombotic microangiopathy in oncology – a review
por: Valério, Patrícia, et al.
Publicado: (2021)

Thrombotic microangiopathy as a complication of recurrent pancreatitis
por: Malleshappa, P., et al.
Publicado: (2011)

Thrombotic microangiopathy with severe renal failure in adenocarcinoma
por: Lakshminarayana, G., et al.
Publicado: (2008)

Pneumococcal Induced T-activation with Resultant Thrombotic Microangiopathy
por: Oliver, J.W., et al.
Publicado: (2010)

Sunitinib induced nephrotic syndrome and thrombotic microangiopathy
por: Jha, P. K., et al.
Publicado: (2013)

A case of pulmonary tumour thrombotic microangiopathy
por: McAnearney, Shane, et al.
Publicado: (2015)

Progressive bevacizumab-associated renal thrombotic microangiopathy*
por: Uy, Alice L., et al.
Publicado: (2009)

Thrombotic microangiopathy as an initial manifestation in HIV patients
por: Dineshkumar, Thanigachalam, et al.
Publicado: (2016)

The use of eculizumab in gemcitabine induced thrombotic microangiopathy
por: Krishnappa, Vinod, et al.
Publicado: (2018)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
por: Baysal, Mehmet, et al.
Publicado: (2018)

Disseminated cerebral aspergillosis complicated by thrombotic microangiopathy
por: Lester, Robynn, et al.
Publicado: (2019)

Thrombotic microangiopathy associated with Valproic acid toxicity
por: Hebert, Sean A., et al.
Publicado: (2017)

The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy
por: Gabr, Jihad Ben, et al.
Publicado: (2020)

Tacrolimus: Transient thrombotic microangiopathy: case report
Publicado: (2020)

Thrombotic microangiopathy secondary to recurrent prostate cancer
por: Newton, Joseph, et al.
Publicado: (2021)

Coronavirus Disease 2019-Associated Thrombotic Microangiopathy
por: Malgaj Vrecko, Marija, et al.
Publicado: (2022)

Carfilzomib-Induced Thrombotic Microangiopathy: Focus on Pathogenesis
por: Eigbire-Molen, Odianosen, et al.
Publicado: (2022)

Narsoplimab for severe transplant-associated thrombotic microangiopathy
por: Pandrowala, Ambreen, et al.
Publicado: (2023)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Thrombotic microangiopathies assessment: mind the complement
por: Blasco, Miquel, et al.
Publicado: (2020)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_79innci1ng95ca8kjj737qve94